“Mifepristone, when delivered via telehealth, is as safe and effective as in-person care," said ANSIRH's @ushma.bsky.social. "If done with integrity, the FDA’s review should confirm its safety and preserve people’s access to this essential care."
The FDA’s ongoing review of mifepristone could skip over established science, health experts warn
